{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:46:52Z","timestamp":1792090012333,"version":"4.4.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA023100-34S3"],"award-info":[{"award-number":["P30 CA023100-34S3"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["U54 CA132384 and U54 CA132379"],"award-info":[{"award-number":["U54 CA132384 and U54 CA132379"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30 AG059299"],"award-info":[{"award-number":["P30 AG059299"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To examine whether measures of health status and quality of life (QoL) were associated with cannabis use after cancer diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Individuals who received care at an NCI-designated cancer center from 2018 to 2019 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20095,901) were invited to complete an online survey in 2022, of which 954 responded. We included 652 respondents in this study, which were weighted to represent the cancer center patient population [58.6% non-Hispanic White; 58.5% female; 51.8%\u2009\u2265\u200965\u00a0years]. We examined three self-rated exposures including physical health, mental health, and QoL each assessed using a single survey item with response options ranging from poor to excellent and dichotomized as \u2018\n                      <jats:italic>Average or Below Average<\/jats:italic>\n                      \u2019 or \u2018\n                      <jats:italic>Above Average\u2019<\/jats:italic>\n                      \u00a0(referent). Post-diagnosis cannabis use was self-reported as \u2018\n                      <jats:italic>Yes<\/jats:italic>\n                      \u2019 or \u2018\n                      <jats:italic>No\u2019<\/jats:italic>\n                      \u00a0(referent). Survey-weighted logistic regression was used to estimate adjusted odds ratios (ORs) and 95% confidence intervals (CIs), and to explore whether these associations differed by cancer stage, treatment status, or pre-diagnosis cannabis use.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Most reported above average status for mental health (67.2%) and QoL (64.2%), and almost\u00a0half (47.1%) reported above average physical health. Odds of post-diagnosis cannabis use were significantly higher among survivors with average or below average mental health (OR\u2009=\u20091.88; 95%CI\u2009=\u20091.13\u20133.11). Associations were positive but not statistically significant for physical health (OR\u2009=\u20091.38; 95%CI\u2009=\u20090.85\u20132.24) and QoL (OR\u2009=\u20091.24; 95%CI\u2009=\u20090.75\u20132.05). These associations did not significantly differ by cancer stage, treatment status, or pre-diagnosis cannabis use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Cancer survivors reporting average or below average health status or QoL had higher odds of cannabis use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00520-026-11185-w","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:55:50Z","timestamp":1788537350000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Post-diagnosis cannabis use and its association with health status and quality of life in cancer survivors"],"prefix":"10.1007","volume":"34","author":[{"given":"Nasim","family":"Kasiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"McDaniels-Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal","family":"Doran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandip P.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Strong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6562-8577","authenticated-orcid":false,"suffix":"Jr","given":"Humberto","family":"Parada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"11185_CR1","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3322\/caac.70011","volume":"75","author":"NS Wagle","year":"2025","unstructured":"Wagle NS, Nogueira L, Devasia TP et al (2025) Cancer treatment and survivorship statistics, 2025. CA Cancer J Clin 75:308\u2013340. https:\/\/doi.org\/10.3322\/caac.70011","journal-title":"CA Cancer J Clin"},{"key":"11185_CR2","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1002\/cncr.23448","volume":"112","author":"KD Stein","year":"2008","unstructured":"Stein KD, Syrjala KL, Andrykowski MA (2008) Physical and psychological long-term and late effects of cancer. Cancer 112:2577\u20132592. https:\/\/doi.org\/10.1002\/cncr.23448","journal-title":"Cancer"},{"key":"11185_CR3","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/MLR.0b013e318045576a","volume":"45","author":"KR Yabroff","year":"2007","unstructured":"Yabroff KR, McNeel TS, Waldron WR et al (2007) Health limitations and quality of life associated with cancer and other chronic diseases by phase of care. Med Care 45:629\u2013637. https:\/\/doi.org\/10.1097\/MLR.0b013e318045576a","journal-title":"Med Care"},{"key":"11185_CR4","doi-asserted-by":"publisher","first-page":"9722","DOI":"10.3390\/curroncol29120763","volume":"29","author":"A Rodriguez-Gonzalez","year":"2022","unstructured":"Rodriguez-Gonzalez A, Velasco-Durantez V, Martin-Abreu C et al (2022) Fatigue, emotional distress, and illness uncertainty in patients with metastatic cancer: results from the prospective NEOETIC_SEOM study. Curr Oncol 29:9722\u20139732. https:\/\/doi.org\/10.3390\/curroncol29120763","journal-title":"Curr Oncol"},{"key":"11185_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.5737\/236880763314","volume":"33","author":"SF Sheikh-Wu","year":"2023","unstructured":"Sheikh-Wu SF, Anglade D, Downs CA (2023) A cancer survivorship model for holistic cancer care and research. Can Oncol Nurs J 33:4\u201316. https:\/\/doi.org\/10.5737\/236880763314","journal-title":"Can Oncol Nurs J"},{"key":"11185_CR6","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_431554","volume":"44","author":"K Gowin","year":"2024","unstructured":"Gowin K, Muminovic M, Zick SM et al (2024) Integrative therapies in cancer care: an update on the guidelines. Am Soc Clin Oncol Educ Book 44:e431554. https:\/\/doi.org\/10.1200\/EDBK_431554","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"11185_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2024.100253","volume":"12","author":"DT Mattingly","year":"2024","unstructured":"Mattingly DT, Richardson MK, Hart JL (2024) Prevalence of and trends in current cannabis use among US youth and adults, 2013\u20132022. Drug Alcohol Depend Rep 12:100253. https:\/\/doi.org\/10.1016\/j.dadr.2024.100253","journal-title":"Drug Alcohol Depend Rep"},{"key":"11185_CR8","doi-asserted-by":"publisher","DOI":"10.1177\/11782218231172054","volume":"17","author":"KN Farrelly","year":"2023","unstructured":"Farrelly KN, Wardell JD, Marsden E et al (2023) The impact of recreational cannabis legalization on cannabis use and associated outcomes: a systematic review. Subst Abuse 17:11782218231172054. https:\/\/doi.org\/10.1177\/11782218231172054","journal-title":"Subst Abuse"},{"key":"11185_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-021-00352-3","volume":"16","author":"K Gali","year":"2021","unstructured":"Gali K, Winter SJ, Ahuja NJ et al (2021) Changes in cannabis use, exposure, and health perceptions following legalization of adult recreational cannabis use in California: a prospective observational study. Subst Abuse Treat Prev Policy 16:16","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"11185_CR10","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1200\/OP.23.00775","volume":"20","author":"IM Braun","year":"2024","unstructured":"Braun IM, Bohlke K, Roeland EJ (2024) Cannabis and cannabinoids in adults with cancer: ASCO guideline Q&A. JCO Oncol Pract 20:767\u2013770. https:\/\/doi.org\/10.1200\/OP.23.00775","journal-title":"JCO Oncol Pract"},{"key":"11185_CR11","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1002\/cncr.32059","volume":"125","author":"KR Tringale","year":"2019","unstructured":"Tringale KR, Huynh-Le M-P, Salans M et al (2019) The role of cancer in marijuana and prescription opioid use in the United States: a population-based analysis from 2005 to 2014. Cancer 125:2242\u20132251. https:\/\/doi.org\/10.1002\/cncr.32059","journal-title":"Cancer"},{"key":"11185_CR12","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/jncimonographs\/lgad024","volume":"2024","author":"C McDaniels-Davidson","year":"2024","unstructured":"McDaniels-Davidson C, Parada H Jr, Kasiri N et al (2024) The association of perceived cannabis risks and benefits with cannabis use since cancer diagnosis. JNCI Monographs 2024:244\u2013251. https:\/\/doi.org\/10.1093\/jncimonographs\/lgad024","journal-title":"JNCI Monographs"},{"key":"11185_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/jncimonographs\/lgae029","author":"GL Ellison","year":"2024","unstructured":"Ellison GL, Helzlsouer KJ, Rosenfield SM et al (2024) Perceptions, prevalence, and patterns of cannabis use among cancer patients treated at 12 NCI-designated Cancer Centers. J Natl Cancer Inst Monogr. https:\/\/doi.org\/10.1093\/jncimonographs\/lgae029","journal-title":"J Natl Cancer Inst Monogr"},{"key":"11185_CR14","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s00520-007-0380-2","volume":"16","author":"DH Henry","year":"2008","unstructured":"Henry DH, Viswanathan HN, Elkin EP et al (2008) Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S. Support Care Cancer 16:791\u2013801","journal-title":"Support Care Cancer"},{"key":"11185_CR15","doi-asserted-by":"publisher","first-page":"7601","DOI":"10.1002\/cam4.4287","volume":"10","author":"DC Roy","year":"2021","unstructured":"Roy DC, Lun R, Wang T-F et al (2021) Life dissatisfaction in Canadians aged 40 and above with cancer and mental health disorders: a cross-sectional study using the Canadian Community Health Survey. Cancer Med 10:7601\u20137609. https:\/\/doi.org\/10.1002\/cam4.4287","journal-title":"Cancer Med"},{"key":"11185_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkae004","volume":"8","author":"S Amin","year":"2024","unstructured":"Amin S, Chae SW, Kawamoto CT et al (2024) Cannabis use among cancer patients and survivors in the United States: a systematic review. JNCI Cancer Spectr 8:pkae004. https:\/\/doi.org\/10.1093\/jncics\/pkae004","journal-title":"JNCI Cancer Spectr"},{"key":"11185_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/jncimonographs\/lgad028","author":"N Kasiri","year":"2024","unstructured":"Kasiri N, Banegas M, Nodora J et al (2024) Cancer stage and consideration of cannabis use among adult cancer survivors in Southern California. J Natl Cancer Inst Monogr. https:\/\/doi.org\/10.1093\/jncimonographs\/lgad028","journal-title":"J Natl Cancer Inst Monogr"},{"key":"11185_CR18","unstructured":"National Cancer Institute (2025) Cancers by body location\/system - NCI. https:\/\/www.cancer.gov\/types\/by-body-location. Accessed 24 Jul 2025"},{"key":"11185_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/00001648-199901000-00008","volume":"10","author":"S Greenland","year":"1999","unstructured":"Greenland S, Pearl J, Robins JM (1999) Causal diagrams for epidemiologic research. Epidemiology 10:37\u201348","journal-title":"Epidemiology"},{"key":"11185_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-06887-1","volume":"20","author":"SL Calcaterra","year":"2020","unstructured":"Calcaterra SL, Burnett-Hartman AN, Powers JD et al (2020) A population-based survey to assess the association between cannabis and quality of life among colorectal cancer survivors. BMC Cancer 20:373. https:\/\/doi.org\/10.1186\/s12885-020-06887-1","journal-title":"BMC Cancer"},{"key":"11185_CR21","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1007\/s10552-021-01468-4","volume":"32","author":"PA Newcomb","year":"2021","unstructured":"Newcomb PA, Ton M, Malen RC et al (2021) Cannabis use is associated with patient and clinical factors in a population-based sample of colorectal cancer survivors. Cancer Causes Control 32:1321\u20131327. https:\/\/doi.org\/10.1007\/s10552-021-01468-4","journal-title":"Cancer Causes Control"},{"key":"11185_CR22","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00520-021-06515-z","volume":"30","author":"SW Nielsen","year":"2022","unstructured":"Nielsen SW, Ruhlmann CH, Eckhoff L et al (2022) Cannabis use among Danish patients with cancer: a cross-sectional survey of sociodemographic traits, quality of life, and patient experiences. Support Care Cancer 30:1181\u20131190. https:\/\/doi.org\/10.1007\/s00520-021-06515-z","journal-title":"Support Care Cancer"},{"key":"11185_CR23","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1177\/10499091221110217","volume":"40","author":"R Nathan","year":"2023","unstructured":"Nathan R, Mupamombe CT, Elibol J et al (2023) Assessing efficacy and use patterns of medical cannabis for symptom management in elderly cancer patients. Am J Hosp Palliat Care 40:368\u2013373. https:\/\/doi.org\/10.1177\/10499091221110217","journal-title":"Am J Hosp Palliat Care"},{"key":"11185_CR24","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1111\/jan.14780","volume":"77","author":"W Xu","year":"2021","unstructured":"Xu W, Gilmer DO, Starkweather A, Kim K (2021) Associations among marijuana use, health-related quality of life, exercise, depression and sleep in cancer survivors. J Adv Nurs 77:2386\u20132397. https:\/\/doi.org\/10.1111\/jan.14780","journal-title":"J Adv Nurs"},{"key":"11185_CR25","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.1002\/cncr.33794","volume":"127","author":"EK Do","year":"2021","unstructured":"Do EK, Ksinan AJ, Kim SJ et al (2021) Cannabis use among cancer survivors in the United States: analysis of a nationally representative sample. Cancer 127:4040\u20134049. https:\/\/doi.org\/10.1002\/cncr.33794","journal-title":"Cancer"},{"key":"11185_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1546447","volume":"15","author":"R Aguiar-Ib\u00e1\u00f1ez","year":"2025","unstructured":"Aguiar-Ib\u00e1\u00f1ez R, Mbous YPV, Sharma S, Chawla E (2025) Assessing the clinical, humanistic, and economic impact of early cancer diagnosis: a systematic literature review. Front Oncol 15:1546447. https:\/\/doi.org\/10.3389\/fonc.2025.1546447","journal-title":"Front Oncol"},{"key":"11185_CR27","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1046\/j.1365-2648.2001.01697.x","volume":"33","author":"M Dodd","year":"2001","unstructured":"Dodd M, Janson S, Facione N et al (2001) Advancing the science of symptom management. J Adv Nurs 33:668\u2013676. https:\/\/doi.org\/10.1046\/j.1365-2648.2001.01697.x","journal-title":"J Adv Nurs"},{"key":"11185_CR28","doi-asserted-by":"publisher","unstructured":"Bender MS, Janson SL, Franck LS, Aldrich Lee K (2018) Theory of symptom management. In: Smith MJ, Liehr PR (eds) Middle range theory for nursing. 4th edn. Springer Publishing Company, pp 147\u2013177.\u00a0https:\/\/doi.org\/10.1891\/9780826159922.0008","DOI":"10.1891\/9780826159922.0008"},{"key":"11185_CR29","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00520-023-07881-6","volume":"31","author":"EA McClure","year":"2023","unstructured":"McClure EA, Walters KJ, Tomko RL et al (2023) Cannabis use prevalence, patterns, and reasons for use among patients with cancer and survivors in a state without legal cannabis access. Support Care Cancer 31:429. https:\/\/doi.org\/10.1007\/s00520-023-07881-6","journal-title":"Support Care Cancer"},{"key":"11185_CR30","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3109\/10673229709030550","volume":"4","author":"EJ Khantzian","year":"1997","unstructured":"Khantzian EJ (1997) The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry 4:231\u2013244. https:\/\/doi.org\/10.3109\/10673229709030550","journal-title":"Harv Rev Psychiatry"},{"key":"11185_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15123190","volume":"15","author":"J Maraud","year":"2023","unstructured":"Maraud J, Bedhomme S, Pereira B et al (2023) Self-medication during and after cancer: a French nation-wide cross-sectional study. Cancers (Basel) 15:3190. https:\/\/doi.org\/10.3390\/cancers15123190","journal-title":"Cancers (Basel)"},{"key":"11185_CR32","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1177\/1534735416660384","volume":"16","author":"PL Judson","year":"2017","unstructured":"Judson PL, Abdallah R, Xiong Y et al (2017) Complementary and alternative medicine use in individuals presenting for care at a comprehensive cancer center. Integr Cancer Ther 16:96\u2013103. https:\/\/doi.org\/10.1177\/1534735416660384","journal-title":"Integr Cancer Ther"},{"key":"11185_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13175217","volume":"13","author":"JC Verster","year":"2024","unstructured":"Verster JC, I\u0161eri\u0107 E, Ulijn GA et al (2024) Single-item assessment of quality of life: associations with well-being, mood, health correlates, and lifestyle. J Clin Med 13:5217. https:\/\/doi.org\/10.3390\/jcm13175217","journal-title":"J Clin Med"},{"key":"11185_CR34","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2466\/pr0.1991.69.1.127","volume":"69","author":"KA Cunny","year":"1991","unstructured":"Cunny KA, Perri M (1991) Single-item vs multiple-item measures of health-related quality of life. Psychol Rep 69:127\u2013130. https:\/\/doi.org\/10.2466\/pr0.1991.69.1.127","journal-title":"Psychol Rep"},{"key":"11185_CR35","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1023\/B:QURE.0000018499.64574.1f","volume":"13","author":"AGEM de Boer","year":"2004","unstructured":"de Boer AGEM, van Lanschot JJB, Stalmeier PFM et al (2004) Is a single-item visual analogue scale as valid, reliable and responsive as multi-item scales in measuring quality of life? Qual Life Res 13:311\u2013320. https:\/\/doi.org\/10.1023\/B:QURE.0000018499.64574.1f","journal-title":"Qual Life Res"},{"key":"11185_CR36","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3390\/ejihpe11010015","volume":"11","author":"JC Verster","year":"2021","unstructured":"Verster JC, Sandalova E, Garssen J, Bruce G (2021) The use of single-item ratings versus traditional multiple-item questionnaires to assess mood and health. Eur J Investig Health Psychol Educ 11:183\u2013198. https:\/\/doi.org\/10.3390\/ejihpe11010015","journal-title":"Eur J Investig Health Psychol Educ"},{"key":"11185_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1027\/1015-5759\/a000699","volume":"38","author":"MS Allen","year":"2022","unstructured":"Allen MS, Iliescu D, Greiff S (2022) Single item measures in psychological science: a call to action. Eur J Psychol Assess 38:1\u20135. https:\/\/doi.org\/10.1027\/1015-5759\/a000699","journal-title":"Eur J Psychol Assess"},{"key":"11185_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e15280","volume":"9","author":"JC Verster","year":"2023","unstructured":"Verster JC, Mulder KE, Verheul MC et al (2023) Test-retest reliability of single-item assessments of immune fitness, mood, and quality of life. Heliyon 9:e15280. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e15280","journal-title":"Heliyon"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11185-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11185-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11185-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:48:08Z","timestamp":1792086488000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11185-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["11185"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-11185-w","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards of the Institutional Review Board of San Diego State University and the University of California San Diego and were in compliance with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study was approved by the San Diego State University Institutional Review Board.","order":1,"name":"Ethics","label":"Ethics declaration","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"931"}}